Hologic Buys TCT International

Hologic (NASDAQ: HOLX), a Bedford, MA-based developer of diagnostic and medical imaging devices, announced today that it has bought Beijing-based TCT International for $135 million in cash, with $35 million of that deferred for one year, plus a two-year contingent earn out. TCT is a distributor of medical products and instruments in China, including Hologic’s ThinPrep Pap Test. “We firmly believe by controlling a distribution channel as extensive as TCT’s, we can better leverage our entire product portfolio to drive growth across multiple market segments,” said Hologic president and CEO Rob Cascella in the announcement of the deal.

Trending on Xconomy